Professional Documents
Culture Documents
Conference
Internal Medicine
EVMC Group D1 EVMC Group D2
Abieras Loyola
Bianes Mazo
Marcellones Navales
Peñ aflor Pelicano
Sabalberino Perez-Gamboa
Sebanes Verunque
UPM-SHS
Dacaya
Ingcog
Inocencio
Yogyog
Objectives:
• To present the case protocol of this clinicopathologic conference
• To formulate a differential diagnosis based on the case
Chief Complaint
•Difficulty of Breathing
History of Present Illness
Smoker
Factory worker
Vital signs:
BP: 120/80mmHg
HR: 109 bpm
RR: 23 cpm
Temp: 37.5 ⁰C
O2 Sat: 99% (intubated)
Height: 168 cm
Weight: 50kg
BMI: 17.7 (Underweight)
Physical Examination
• Weak grip
• DTRs 2+
• No sensory deficits
• CN – not mentioned
Complete Blood Count (Day 1)
Parameter Result Reference range Remarks
Hemoglobin 180 140-170 g/L High
Hematocrit 0.513 0.42–0.52
WBC 29.7 4.8-10.8 x 109/L High
Segmenters 0.89 0.43-0.65 High
Lymphocytes 0.08 0.20-0.45 Low
Monocytes 0.03 0.05-0.12 Low
Platelets 259 150-400 x 109/L
Neutrophil-Lymphocyte Ratio: 11
Blood Chemistry (First Hospital Day)
Interpretation:
High Anion Gap Metabolic Acidosis with Respiratory Acidosis, Hyperoxemia
Interpretation:
ECG
Sinus rhythm, Normal rate
No axis deviation
No chamber enlargement
No ischemic changes
Presence of U-waves
Chest Xray (PA view)
Upon Admission
• Fed via NGT
• IVF line with KCL side drips
• KCL tab TID
• Omeprazole 40mg/IV OD
• NaHCO3 tab OD
• Piperazillin-Tazobactam
IVTT q6
2nd Day of (+) Febrile Episodes
Admission (+) Dyspnea
(+) Awake, alert, agitated but follows commands
VS:
BP: 110/70 mmHg (normotensive)
HR: 130 mmHg (Tachycardic)
RR: 30s-40s cpm (Tachypneic)
T: 38.2C (Febrile)
O2 Sat: 99% (intubated)
(+) Minimal coffee ground secretions per NGT
(-) Secretions per ET
18 ml/min/1.73
m2 8 ml/ min/1.73 m2
eGFR (Stage IV Severe (Stage V – Kidney
loss of kidney Failure)
function)
CBGs: 94g/dL
ECG: Sinus tachycardia
Leptospirosis IgG, IgM – Negative
Started NE Drip (0.5mkm at 50kg), KCl tab shifted to K Citrate tab q6,
Cont. Omeprazole Drip, Piperacillin Tazobactam IVTT q6h, NAHCO3
Drip and Paracetamol RTC IVTT
Blood Chemistry
Parameter Day 1 Day 2 Day 3 Reference range
131.5 154.7 168.1 (Hypernatremia)
Sodium (Hypernatremia) 135–148 mmol/L
(Hyponatremia)
1.03 (Hypokalemia - 3.67 4.76
Potassium 3.5–5.3 mmol/L
Severe)
96.3 120.5 130.3 (Hyperchloremia)
Chloride (Hyperchloremia) 98-107 mmol/L
(Hypochloremia)
Magnesium 0.93 1.08 0.74–1.03 mmol/L
Calcium 1.39 (Hypercalcemia) 1.42 (Hypercalcemia) 1–1.3 mmol/L
3.91
Phosphorus (Hyperphosphatemia) 0.81–1.49 mmol/L
27 25 L
Albumin (Hypoalbuminemia) 35–50 g/L
TSH 0.047 L
Troponin I 0.13 0-0.6 µg/L
AST 751 H 15-41 U/L
ALT 179 H 17-63 U/L
Day 3
Parameter Day 1 Day 2 Reference range
671.2 H 1092 H
Creatinine 346.8 H 80-115 umol/L
38.0 H 47.6 H
BUN 18.3 H 2.9-9.3 mmol/L
18
ml/min/1.73 5 ml/ min/1.73 m2
m2 8 ml/ min/1.73 m2
eGFR (Stage IV (Stage V CKD by (Stage V CKD by
CKD by CKD- CKD-EPI creatinine) CKD-EPI
EPI creatinine)
creatinine)
BUN:Crea
1: 18.9 1:17.66 1:22.94
Ratio
Referred to General Surgery:
IJ catheter and CV line insertion
Cardiopulmonary arrest
Expired.
PIVOT: Weakness
Weakness
45 y/o
Male
Factory Worker
SSx:
Body weakness
Difficulty moving all extremities
Syndrome of: Decrease in appetite
Hypokalemia Nausea and vomiting
Decreased bilateral breath sounds
Serum Electrolytes: K+ 1.03 (Dec. Severe)
Presence of U waves
Low Plasma HCO3
Castro D, Sharma S. Hypokalemia. [Updated 2021 Jul 20]. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482465
Body weakness
Difficulty moving all extremities
Syndrome of: Decrease in appetite
Hypokalemia Nausea and vomiting
Decreased bilateral breath sounds
Serum Electrolytes: K+ 1.03 (Dec. Severe)
Presence of U waves
Low Plasma HCO3
Diuretic Use?
Chronic Diarrhea? Laxative Use?
Previous colon surgery? Salicylate Use?
No
No
Diuretic Use?
Chronic Diarrhea? Laxative Use?
Previous colon surgery? Salicylate Use?
No
No
K+ 1.03 (Severe)
Presence of U waves in
Severe Renal Injury
pH: 7.06.995
ECG Hypokalemia HCO3 12.1 8.5
Metabolic Acidosis
Hyperpolarization Uremia
of Cell membranes
(+) Vomiting
Impaired Neural Reduced Neural Reduced (+) Changes in Sensorium
(+) Body Weakness
Conduction to Conduction to Neural (+) Dyspnea/ Respiratory
Muscles Respiratory Conduction to Distress
Muscles ENS (+) Elevated BUN
(+) Elevated Crea
(+) Weakness
(+) Inability to Respiratory GI Paralysis/
Ambulate Depression Ileus
Inability to
Decreased Breath Sounds Protect Airway
Hypoventilation
CO2 Nausea, Vomiting
Dyspnea
Retention Decreased Appetite
Desaturation
Decreased Sensorium Metabolic Acidosis
Mental Status Changes Persisting despite
Respiratory Acidosis
treatment
Increased Risk for Pneumonia
Possible Aspiration Component
(+) Cough
CXR: Infiltrates
Right Middle Lobe
Sepsis
Coffee Ground
NGT Secretions
RTA Type II
HCO3 Depletion
re Renal Injury
pH: 7.06.995
lemia HCO3 12.1 8.5
Metabolic Acidosis
Uremia
(+) Vomiting
ral Reduced (+) Changes in Sensorium
(+) Body Weakness
to Neural (+) Dyspnea/ Respiratory
y Conduction to Distress
ENS (+) Elevated BUN
(+) Elevated Crea
RTA Type II
Hyperpolarization
of Cell membranes
(+)
Impaired Neural Reduced Neural Reduced (+)
(+)
Conduction to Conduction to Neural (+)
Muscles Respiratory Conduction to Dist
Muscles ENS (+)
(+)
(+) Weakness
(+) Inability to
K+ Depletion HCO3 Depletion
K+ 1.03 (Severe)
Presence of U waves in
Severe
pH: 7.06.995
ECG Hypokalemia HCO3 12.1 8.5
Metabolic Acidosis
Hyperpolarization
of Cell membranes
(+) Vom
Impaired Neural Reduced Neural Reduced (+) Cha
(+) Bod
Conduction to Conduction to Neural (+) Dys
Muscles Respiratory Conduction to Distres
Muscles ENS (+) Elev
(+) Elev
(+) Weakness
(+) Inability to Respiratory GI Paralysis/
Ambulate Depression Ileus
Inability to
Decreased Breath Sounds Protect Airway
Hypoventilation
Presence of U waves in pH: 7.06.995
ECG Hypokalemia HCO3 12.1 8.5
Metabolic Acidosis
Hyperpolarization
of Cell membranes
(+) Vomi
Impaired Neural Reduced Neural Reduced (+) Chang
(+) Body
Conduction to Conduction to Neural (+) Dyspn
Muscles Respiratory Conduction to Distress
Muscles ENS (+) Eleva
(+) Eleva
(+) Weakness
(+) Inability to Respiratory GI Paralysis/
Ambulate Depression Ileus
Inability to
Decreased Breath Sounds Protect Airway
Hypoventilation
CO2 Nausea, Vomiting
Dyspnea
Retention Decreased Appetite
Desaturation
Decreased Sensorium Metabolic Acidosis
Mental Status Changes Persisting despite
Respiratory Acidosis
treatment
Increased Risk for Pneumonia
Possible Aspiration Component
Inability to
Decreased Breath Sounds Protect Airway
Hypoventilation
CO2 Nausea, Vomiting
Dyspnea
Retention Decreased Appetite
Desaturation
Decreased Sensorium Metabolic Acidosis
Mental Status Changes Persisting despite
Respiratory Acidosis
treatment
Increased Risk for Pneumonia
Possible Aspiration Component
(+) Cough
CXR: Infiltrates
Right Middle Lobe
Sepsis
Coffee Ground
NGT Secretions
Final Diagnosis